Arterys, a US-based medical imaging technology developer, closed a $30m series B round on Wednesday that featured corporates including diversified conglomerate Fosun International and oncology radiation system provider Varian Medical Systems.
Healthcare providers Northwell Health and NewYork-Presbyterian also took part in the round, the latter through its Northwell Health Ventures unit, as did GE Ventures, a subsidiary of industrial equipment and appliance producer General Electric.
The round also included Singaporean state-owned investment firm Temasek and venture capital firms Emergent Medical Partners and Ori Capital.
Founded in 2011, Arterys has developed a cloud-based, artificial intelligence (AI)-equpped medical image analytics platform. Its first product, which has been cleared for use in the US, Canada and Europe, is a diagnostic support tool for cardiac magnetic resonance imaging (MRI).
The company claims its platform and cardiac MRI suite have been used to aid the diagnosis of more than 15,000 patients worldwide. It plans to use the funding to expand its platform and launch new oncology and neurology products.
Arterys had previously raised $12m in a March 2016 series A round backed by GE Ventures, Emergent Medical Partners, Stanford-StartX Fund, Norwich Ventures, Asset Management Ventures, AME Cloud Ventures and Morado Ventures.
Fabien Beckers, founder and CEO of Arterys, said: “This financing includes pioneers in healthcare who recognise the game-changing value of a cloud AI platform to unlock the potential of radiology data to improve patient care.
“We are excited to grow our offerings and work with our clinical partners in building powerful, accessible tools for the medical imaging community to accelerate the transition to data-driven medicine.”